Cargando…
Antipsychotics and COVID-19: the debate goes on
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601681/ https://www.ncbi.nlm.nih.gov/pubmed/34801118 http://dx.doi.org/10.1016/S2215-0366(21)00396-5 |
| _version_ | 1784601408251625472 |
|---|---|
| author | Boland, Xavier Dratcu, Luiz |
| author_facet | Boland, Xavier Dratcu, Luiz |
| author_sort | Boland, Xavier |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8601681 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86016812021-11-19 Antipsychotics and COVID-19: the debate goes on Boland, Xavier Dratcu, Luiz Lancet Psychiatry Correspondence Elsevier Ltd. 2021-12 2021-11-18 /pmc/articles/PMC8601681/ /pubmed/34801118 http://dx.doi.org/10.1016/S2215-0366(21)00396-5 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Boland, Xavier Dratcu, Luiz Antipsychotics and COVID-19: the debate goes on |
| title | Antipsychotics and COVID-19: the debate goes on |
| title_full | Antipsychotics and COVID-19: the debate goes on |
| title_fullStr | Antipsychotics and COVID-19: the debate goes on |
| title_full_unstemmed | Antipsychotics and COVID-19: the debate goes on |
| title_short | Antipsychotics and COVID-19: the debate goes on |
| title_sort | antipsychotics and covid-19: the debate goes on |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601681/ https://www.ncbi.nlm.nih.gov/pubmed/34801118 http://dx.doi.org/10.1016/S2215-0366(21)00396-5 |
| work_keys_str_mv | AT bolandxavier antipsychoticsandcovid19thedebategoeson AT dratculuiz antipsychoticsandcovid19thedebategoeson |